Matches in DBpedia 2015-10 for { <http://dbpedia.org/resource/TM-38837> ?p ?o }
Showing triples 1 to 72 of
72
with 100 triples per page.
- TM-38837 abstract "TM-38837 is a small molecule inverse agonist/antagonist of the CB1 cannabinoid receptor, with peripheral selectivity. It is being developed for the treatment of obesity and metabolic disorders by 7TM Pharma. The company has announced phase I clinical trials.TM-38837 is among the first of a new generation of cannabinoid receptor antagonist designed to avoid the central nervous system liabilities of the first generation CB1 receptor antagonists such as rimonabant.".
- TM-38837 atcPrefix "none".
- TM-38837 iupacName "1-(2,4-Dichlorophenyl)-4-ethyl-5-(5-(2-(4-(trifluoromethyl)phenyl)ethynyl)thiophen-2-yl)-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide".
- TM-38837 pubchem "49779607".
- TM-38837 thumbnail TM-38837.svg?width=300.
- TM-38837 wikiPageExternalLink iaft-eod070810.php.
- TM-38837 wikiPageID "30517438".
- TM-38837 wikiPageLength "3188".
- TM-38837 wikiPageOutDegree "11".
- TM-38837 wikiPageRevisionID "678221728".
- TM-38837 wikiPageWikiLink AM-6545.
- TM-38837 wikiPageWikiLink Cannabinoid_receptor_antagonist.
- TM-38837 wikiPageWikiLink Cannabinoid_receptor_type_1.
- TM-38837 wikiPageWikiLink Category:Anorectics.
- TM-38837 wikiPageWikiLink Category:CB1_receptor_antagonists.
- TM-38837 wikiPageWikiLink Central_nervous_system.
- TM-38837 wikiPageWikiLink Inverse_agonist.
- TM-38837 wikiPageWikiLink Obesity.
- TM-38837 wikiPageWikiLink Phases_of_clinical_research.
- TM-38837 wikiPageWikiLink Receptor_antagonist.
- TM-38837 wikiPageWikiLink Rimonabant.
- TM-38837 wikiPageWikiLinkText "TM-38837".
- TM-38837 atcPrefix "none".
- TM-38837 c "30".
- TM-38837 chemspiderid "29361353".
- TM-38837 cl "2".
- TM-38837 f "3".
- TM-38837 h "25".
- TM-38837 hasPhotoCollection TM-38837.
- TM-38837 inchi "1".
- TM-38837 inchikey "VQOCBFYUDSBDCZ-UHFFFAOYAI".
- TM-38837 iupacName "1".
- TM-38837 legalStatus "?".
- TM-38837 molecularWeight "617.51".
- TM-38837 n "4".
- TM-38837 o "1".
- TM-38837 pubchem "49779607".
- TM-38837 s "1".
- TM-38837 smiles "O=CNN5CCCCC5".
- TM-38837 stdinchi "1".
- TM-38837 stdinchikey "VQOCBFYUDSBDCZ-UHFFFAOYSA-N".
- TM-38837 width "275".
- TM-38837 wikiPageUsesTemplate Template:Cannabinoid-stub.
- TM-38837 wikiPageUsesTemplate Template:Cannabinoids.
- TM-38837 wikiPageUsesTemplate Template:Dead_link.
- TM-38837 wikiPageUsesTemplate Template:Drugbox.
- TM-38837 wikiPageUsesTemplate Template:Reflist.
- TM-38837 wikiPageUsesTemplate Template:Third-party.
- TM-38837 subject Category:Anorectics.
- TM-38837 subject Category:CB1_receptor_antagonists.
- TM-38837 hypernym Antagonist.
- TM-38837 type Article.
- TM-38837 type ChemicalSubstance.
- TM-38837 type Drug.
- TM-38837 type Antagonist.
- TM-38837 type Article.
- TM-38837 type Cannabinoid.
- TM-38837 type Chemical.
- TM-38837 type Drug.
- TM-38837 type ChemicalObject.
- TM-38837 type Thing.
- TM-38837 type Q8386.
- TM-38837 comment "TM-38837 is a small molecule inverse agonist/antagonist of the CB1 cannabinoid receptor, with peripheral selectivity. It is being developed for the treatment of obesity and metabolic disorders by 7TM Pharma. The company has announced phase I clinical trials.TM-38837 is among the first of a new generation of cannabinoid receptor antagonist designed to avoid the central nervous system liabilities of the first generation CB1 receptor antagonists such as rimonabant.".
- TM-38837 label "TM-38837".
- TM-38837 sameAs m.0g9yb7l.
- TM-38837 sameAs TM-38837.
- TM-38837 sameAs TM-38837.
- TM-38837 sameAs Q7670627.
- TM-38837 sameAs Q7670627.
- TM-38837 wasDerivedFrom TM-38837?oldid=678221728.
- TM-38837 depiction TM-38837.svg.
- TM-38837 isPrimaryTopicOf TM-38837.